Steward Partners Investment Advisory LLC Reduces Stock Position in CVS Health Corporation $CVS

Steward Partners Investment Advisory LLC decreased its holdings in CVS Health Corporation (NYSE:CVS) by 1.5% during the second quarter, HoldingsChannel.com reports. The firm owned 59,676 shares of the pharmacy operator’s stock after selling 939 shares during the quarter. Steward Partners Investment Advisory LLC’s holdings in CVS Health were worth $4,116,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Avion Wealth grew its holdings in shares of CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares during the last quarter. Harbor Asset Planning Inc. bought a new position in CVS Health in the 2nd quarter worth about $30,000. Bell Investment Advisors Inc increased its position in shares of CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 248 shares during the period. Roxbury Financial LLC increased its position in shares of CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 202 shares during the period. Finally, ORG Partners LLC raised its stake in shares of CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 377 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Price Performance

CVS opened at $79.88 on Friday. The firm has a market capitalization of $101.40 billion, a PE ratio of 210.22, a price-to-earnings-growth ratio of 0.87 and a beta of 0.60. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.62. The business’s 50-day moving average is $78.53 and its two-hundred day moving average is $70.59. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. During the same period last year, the business earned $1.09 EPS. The company’s revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Research analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s payout ratio is currently 700.00%.

Analyst Ratings Changes

Several research analysts have commented on CVS shares. Royal Bank Of Canada raised their price objective on CVS Health from $81.00 to $93.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Weiss Ratings reissued a “hold (c-)” rating on shares of CVS Health in a research report on Monday. Wells Fargo & Company decreased their price objective on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a report on Thursday, November 13th. Evercore ISI increased their target price on shares of CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Finally, Jefferies Financial Group raised their target price on shares of CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. Two research analysts have rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and a consensus price target of $89.41.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.